SE430063B - 5-fenyl-2-oxazolkarboximidamider - Google Patents

5-fenyl-2-oxazolkarboximidamider

Info

Publication number
SE430063B
SE430063B SE7811577A SE7811577A SE430063B SE 430063 B SE430063 B SE 430063B SE 7811577 A SE7811577 A SE 7811577A SE 7811577 A SE7811577 A SE 7811577A SE 430063 B SE430063 B SE 430063B
Authority
SE
Sweden
Prior art keywords
mol
solid
mixture
hours
give
Prior art date
Application number
SE7811577A
Other languages
English (en)
Swedish (sv)
Other versions
SE7811577L (sv
Inventor
Jr R L White
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of SE7811577L publication Critical patent/SE7811577L/xx
Publication of SE430063B publication Critical patent/SE430063B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7811577A 1978-02-27 1978-11-09 5-fenyl-2-oxazolkarboximidamider SE430063B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/881,827 US4151168A (en) 1978-02-27 1978-02-27 5-Phenyl-2-oxazole carboximidamides as antidepressants

Publications (2)

Publication Number Publication Date
SE7811577L SE7811577L (sv) 1979-08-28
SE430063B true SE430063B (sv) 1983-10-17

Family

ID=25379300

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7811577A SE430063B (sv) 1978-02-27 1978-11-09 5-fenyl-2-oxazolkarboximidamider

Country Status (15)

Country Link
US (1) US4151168A (es)
JP (1) JPS54115371A (es)
AU (1) AU518273B2 (es)
BE (1) BE873853A (es)
CA (1) CA1106385A (es)
CH (1) CH638505A5 (es)
DE (1) DE2907199A1 (es)
ES (1) ES477715A1 (es)
FR (1) FR2418229A1 (es)
GB (1) GB2014988B (es)
IE (1) IE47412B1 (es)
IT (1) IT1115788B (es)
MX (1) MX5082E (es)
NL (1) NL190774C (es)
SE (1) SE430063B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59135008U (ja) * 1983-02-28 1984-09-10 松下電工株式会社 分電盤装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL135043C (es) * 1963-10-11
US3399209A (en) * 1964-12-18 1968-08-27 Monsanto Chem Australia Ltd 2-(2'-oxazolin-2'-yl)-benzimidazoles
FR1537684A (fr) * 1965-12-29 1968-09-07 Monsanto Chem Australia Ltd Procédé de préparation des 2-azolin-2-yl-benzimidazoles

Also Published As

Publication number Publication date
US4151168A (en) 1979-04-24
NL190774C (nl) 1994-08-16
NL190774B (nl) 1994-03-16
DE2907199C2 (es) 1988-03-24
IT7947857A0 (it) 1979-02-01
GB2014988A (en) 1979-09-05
FR2418229B1 (es) 1983-03-18
IE782133L (en) 1979-08-27
IT1115788B (it) 1986-02-03
AU518273B2 (en) 1981-09-24
NL7900239A (nl) 1979-08-29
FR2418229A1 (fr) 1979-09-21
CA1106385A (en) 1981-08-04
JPS54115371A (en) 1979-09-07
BE873853A (fr) 1979-07-31
SE7811577L (sv) 1979-08-28
CH638505A5 (de) 1983-09-30
IE47412B1 (en) 1984-03-07
DE2907199A1 (de) 1979-08-30
JPS5523827B2 (es) 1980-06-25
AU4123278A (en) 1979-09-06
ES477715A1 (es) 1980-04-01
MX5082E (es) 1983-03-14
GB2014988B (en) 1982-06-09

Similar Documents

Publication Publication Date Title
CA2131680C (en) Process for preparing imidazopyridine derivatives
US20060063927A1 (en) Processes for preparing quetiapine and salts thereof
JP2007533727A (ja) バルサルタンおよびその前駆体の製造方法
BR112016018581B1 (pt) Processo para a fabricação de derivados de sulfamida pirimidina
JP2020528064A (ja) Lfa−1拮抗薬リフィテグラストを調製および精製するためのプロセス
FI63573C (fi) Foerfarande foer framstaellning av oxibensotiazin-dioxiders kaboxamider
SE454173B (sv) 4h-1,2,4-triazolderivat till anvendning som terapeutikum, farmaceutiska kompositioner innehallande nemnda derivat, nya 4h-1,2,4-triazolderivat samt forfarande for deras framstellning
Heindel et al. 7H-[1, 2, 4] Triazolo [5, 1-b][1, 3] thiazin-7-ones by deamination cyclization of S-acrylates of 4-amino-3 (3H)-1, 2, 4-triazolethiones
SE430063B (sv) 5-fenyl-2-oxazolkarboximidamider
RU2194706C2 (ru) Способ получения дигидрохлорида 1-[[[5-(4-хлорфенил)-2-фуранил]метилен]амино]-3-[4-(4-метил-1-пиперазинил) бутил]-2,4-имидазолидиндиона
US20070027324A1 (en) Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds
WO2018094127A1 (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
JP2001064282A (ja) イミダゾリン化合物、その中間体、およびそれらの製造方法、並びにアゼピン化合物およびその塩の製造方法
KR20230043107A (ko) 아미노푸란을 제조하는 방법
JP5033933B2 (ja) N−置換−2−アミノ−4−(ヒドロキシメチルホスフィニル)−2−ブテン酸の製造法
CN106316885B (zh) 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法
EP2417113B1 (en) Process for the preparation of pyrimidine derivatives
US2719849A (en) beta-(1, 2, 4-triazolyl-3)-alanine and its salts and the preparation thereof
SE441923B (sv) 1-acyl-2-imidazolin till anvendning som mellanprodukt vid framstellning av 1-osubstituerad-2-imidazolin samt forfarande for dess framstellning
CN112272665A (zh) 制备立他司特的方法
KR860001568B1 (ko) 선택적 설폰화 방법에 의한 페닐렌디아민 유도체의 제조 방법
US4395547A (en) Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
JP2831000B2 (ja) (2−アミノベンゾイル)酢酸エステル誘導体
Soleiman et al. Synthesis of 3‐Substituted Benzpyrid‐4‐imino‐2‐oxime Derivatives
Depreux et al. An improved synthesis of α, β methylenic cyclic ketones

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7811577-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7811577-1

Format of ref document f/p: F